review quotes glp-1 FDA issued 25 warning letters to telehealth companies for false and misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of GLP-1 meds are a hot
Description
A pivotal 2021 clinical trial of semaglutide showed that participants lost an average of 15% of their body weight over 68 weeks, compared to just 2% in the placebo group
This serious eye condition reduces blood flow to the optic nerve and can cause sudden blindness or permanent vision loss
Recalls & Warnings August 01, 2013 Maker of Algae Products Warned For Drug Claims, Manufacturing Violations On March 8, 2013, the FDA issued a warning letter to Algaen Corporation following a facility inspection and website review which found statements made about the company's AlgaBerry products to be drug claims
Not just obesity: GLP-1 receptor agonists advance on addiction
Gejl M, Gjedde A, Egefjord L, et al
If kidney function declines, dose reduction or discontinuation may be necessary
